Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:administered_by |
injection
|
| gptkbp:age_group |
9 to 45 years
|
| gptkbp:approves |
gptkb:2014
gptkb:U._S._Food_and_Drug_Administration_(FDA) |
| gptkbp:available_in |
multiple countries
|
| gptkbp:clinical_trial |
conducted for safety and efficacy
|
| gptkbp:contains |
9 HPV types
|
| gptkbp:developed_by |
gptkb:Merck_&_Co.
|
| gptkbp:formulation |
quadrivalent and nonavalent
|
| https://www.w3.org/2000/01/rdf-schema#label |
Gardasil 9
|
| gptkbp:indication |
prevention of HPV-related cancers
|
| gptkbp:is_effective_against |
over 90% against targeted HPV types
|
| gptkbp:is_recommended_by |
gptkb:Centers_for_Disease_Control_and_Prevention_(CDC)
|
| gptkbp:marketed_as |
gptkb:Gardasil_9
|
| gptkbp:requires |
multiple doses
|
| gptkbp:side_effect |
fatigue
headache nausea fever pain at injection site |
| gptkbp:targets |
gptkb:human_papillomavirus_(HPV)
|
| gptkbp:bfsParent |
gptkb:human_papillomavirus
|
| gptkbp:bfsLayer |
6
|